NEW YORK (GenomeWeb) – Dutch genetic testing firm GenDx announced yesterday that it has received CE-IVD certification for its NGSengine software.

The software provides analysis of human leukocyte antigen (HLA) typing by next-generation sequencing on several platforms, including Illumina's MiSeq, Thermo Fisher Scientific's IonTorrent PGM, and Pacific Biosciences' PacBio RSII. It includes whole gene representation, automatic allele assignment and multi loci analysis, and simultaneous genotyping of multiple HLA loci, as well as a variety of reviewing and reporting options.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Dec
05
Sponsored by
Agilent

This webinar will discuss a molecular barcode-based error correction method that enables combined mutation detection and DNA copy number profiling through circulating tumor DNA sequencing.